Abiopharma

Chang Kathryn M. 🔴 sold 637 shares of MONRO, INC. (MNRO) Transaction Date: Jun 13, 2026 | Filing ID: 279534

New Form 4/A - GLAUKOS Corp <b>Filed:</b> 2026-06-23 <b>AccNo:</b> 0001529196-26-000006 <b>Size:</b> 5 KB

Director WITTE OWEN N. 🟢 acquired 95.4K shares (1 derivative) of Allogene Therapeutics, Inc. (ALLO) Transaction Date: Jun 18, 2026 | Filing ID: 000002

📋 MARSHALL FORDYCE (Director) plans to sell 74K shares of Vera Therapeutics, Inc. (at $38.43 each, total $2.8M) Filed: Jun 23, 2026 | ID: 006433

📋 SCOTT BIZILY (Officer) plans to sell 10K shares of 4D Molecular Therapeutics, Inc. (at $10.42 each, total $102K) Filed: Jun 23, 2026 | ID: 006432

Director NEITHERCUT DAVID J 🟢 acquired 51.0K shares (2 derivative) of EQUITY RESIDENTIAL (EQR) at $64.09 ($3.3M) Transaction Date: Jun 18, 2026 | Filing ID: 000027

PFENNIGER RICHARD C JR 🟡 adjusted position in 4.2K shares (2 derivative) of GeneDx Holdings Corp. (WGS) Transaction Date: Jun 18, 2026 | Filing ID: 000002

📋 OMNADORA CAPITAL LLC (Director) plans to sell 108K shares of CoreWeave, Inc. (at $111.29 each, total $12.0M) Filed: Jun 23, 2026 | ID: 006431

(99% Neutral) ENERGY FUELS INC (UUUU) Files Form 8-K

(99% Neutral) ASHFORD HOSPITALITY TRUST INC (AHT) Files Form 8-K